Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
The Future is Now: Evolution in the Prevention and Treatment of Venous Thromboembolic Disease
Track: Educational Sessions (CE)
Program Code: 209-L01
Date: Monday, December 7, 2009
Time: 2:00 PM to 5:00 PM EST
Location: 3201A - Murano
MEETING PLANNING ASSOCIATE:   Click the plus sign to see more detailed information about each speaker.
 Michael Gulseth, PharmD, BCPS, Program Director for Anticoagulation Services, Sanford USD Medical Center, Department of Pharmaceutical Services
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Michael Crouch, PharmD, BCPS, Professor and Chair, South University School of Pharmacy
 Michael Gulseth, PharmD, BCPS, Program Director for Anticoagulation Services, Sanford USD Medical Center, Department of Pharmaceutical Services
 Edith Nutescu, PharmD, FCCP, Clinical Professor and Director, Antithrombosis Center, University of Illinois at Chicago
 Ann Wittkowsky, PharmD, CACP, Director, Anticoagulation Services, University of Washington Medical Center
Description
ACPE Activity #204-000-09-209-L01P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Michael P. Gulseth, PharmD, BCPS,
Program Director for Anticoagulation Services, Sanford USD Medical Center, Department of Pharmaceutical Services, Sioux Falls, SD

2:00 p.m. - 2:10 p.m.
Announcements and Welcome

2:10 p.m. - 2:45 p.m.
Research Developments with Current Anticoagulants: How Does this Change Care?
Edith A. Nutescu, PharmD, FCCP,
Clinical Professor and Director, Antithrombosis Center, University of Illinois at Chicago, Chicago

2:45 p.m. - 3:25 p.m.
Comprehensive Review of the Pharmacokinetic/Pharmacodynamic Profiles of the New and Emerging Anticoagulants: What New Tricks Do We Need to Learn?
Ann K. Wittkowsky, PharmD, CACP,
Director, Anticoagulation Services, University of Washington Medical Center, Seattle

3:25 p.m. - 4:05 p.m.
Comprehensive Review of the Clinical Trials Involving New and Emerging Anticoagulants: What is Their Potential Place in Therapy?
Michael A. Crouch, PharmD, BCPS, FASHP,
Professor and Chair, South University School of Pharmacy, Savannah, GA

4:05 p.m. - 4:40 p.m.
Case Discussions: How Do We Apply This Information to Patient Care?
Michael P. Gulseth


4:40 p.m. - 5:00 p.m.
Questions, Answers, and Discussion

Learning Objectives:

  • Compare and contrast new research involving current anticoagulants and describe the implications on therapy.
  • Describe the pharmacology of pharmacokinetics of newly approved or emerging anticoagulants.
  • Identify critical trials involving new and emerging anticoagulants, and speculate on the appropriate role in therapy for these agents.
  • Through the use of case studies, apply the new research to patient care to help determine implications on therapy.


Audio Synchronized to PowerPoint
(Code: 209-L01)
Attendee:Free
  
This session is a part of:
Handout Online
View